Brookstone Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$46.8M Buy
184,287
+106,805
+138% +$24.9M 0.47% 47
2026
Q1
$18.9M Buy
77,482
+5,446
+8% +$1.27M 0.22% 121
2025
Q4
$14.9M Buy
72,036
+811
+1% +$160K 0.17% 146
2025
Q3
$13.2M Sell
71,225
-4,203
-6% -$720K 0.16% 156
2025
Q2
$11.5M Buy
75,428
+1,884
+3% +$290K 0.15% 167
2025
Q1
$12.2M Buy
73,544
+1,199
+2% +$188K 0.17% 145
2024
Q4
$10.5M Sell
72,345
-1,466
-2% -$227K 0.15% 164
2024
Q3
$12M Buy
73,811
+3,842
+5% +$612K 0.18% 135
2024
Q2
$11M Sell
69,969
-16,547
-19% -$2.46M 0.18% 134
2024
Q1
$13.7M Buy
86,516
+17,237
+25% +$2.74M 0.24% 95
2023
Q4
$10.9M Buy
69,279
+683
+1% +$105K 0.21% 125
2023
Q3
$10.4M Buy
68,596
+11,643
+20% +$1.92M 0.23% 125
2023
Q2
$9.07M Sell
56,953
-1,469
-3% -$237K 0.18% 140
2023
Q1
$9.68M Buy
58,422
+1,097
+2% +$177K 0.19% 136
2022
Q4
$10.3M Buy
57,325
+491
+0.9% +$84.8K 0.21% 125
2022
Q3
$9.25M Sell
56,834
-3,079
-5% -$521K 0.21% 123
2022
Q2
$10.7M Buy
59,913
+2,912
+5% +$519K 0.24% 104
2022
Q1
$10.3M Buy
57,001
+437
+0.8% +$74.4K 0.2% 107
2021
Q4
$9.84M Sell
56,564
-33
-0.1% -$5.4K 0.17% 121
2021
Q3
$9.01M Buy
56,597
+4,875
+9% +$832K 0.16% 121
2021
Q2
$8.76M Buy
51,722
+21,460
+71% +$3.55M 0.16% 127
2021
Q1
$4.97M Buy
30,262
+2,253
+8% +$365K 0.19% 102
2020
Q4
$4.41M Sell
28,009
-2,398
-8% -$354K 0.18% 104
2020
Q3
$4.53M Buy
30,407
+4,981
+20% +$737K 0.21% 74
2020
Q2
$3.58M Sell
25,426
-834
-3% -$122K 0.22% 67
2020
Q1
$3.44M Sell
26,260
-4,832
-16% -$686K 0.2% 67
2019
Q4
$4.54M Sell
31,092
-1,267
-4% -$172K 0.23% 66
2019
Q3
$4.19M Sell
32,359
-5,778
-15% -$761K 0.23% 70
2019
Q2
$5.31M Buy
38,137
+16,221
+74% +$2.25M 0.31% 58
2019
Q1
$3.06M Sell
21,916
-1,086
-5% -$145K 0.2% 77
2018
Q4
$2.97M Sell
23,002
-781
-3% -$109K 0.23% 77
2018
Q3
$3.29M Buy
23,783
+5,740
+32% +$763K 0.25% 109
2018
Q2
$2.19M Sell
18,043
-4,074
-18% -$508K 0.19% 113
2018
Q1
$2.83M Buy
22,117
+513
+2% +$69.3K 0.26% 102
2017
Q4
$3.02M Sell
21,604
-38,631
-64% -$5.38M 0.27% 102
2017
Q3
$7.83M Sell
60,235
-3,575
-6% -$474K 0.71% 34
2017
Q2
$8.44M Sell
63,810
-203
-0.3% -$25.9K 0.8% 31
2017
Q1
$7.97M Buy
64,013
+5,795
+10% +$692K 0.81% 34
2016
Q4
$6.71M Buy
58,218
+8,215
+16% +$949K 0.74% 43
2016
Q3
$5.91M Buy
50,003
+2,862
+6% +$347K 0.65% 41
2016
Q2
$5.72M Buy
47,141
+6,708
+17% +$762K 0.75% 25
2016
Q1
$4.37M Buy
40,433
+25,106
+164% +$2.6M 0.66% 24
2015
Q4
$1.57M Buy
15,327
+552
+4% +$55.5K 0.3% 42
2015
Q3
$1.38M Sell
14,775
-34,965
-70% -$3.38M 0.25% 36
2015
Q2
$4.85M Buy
49,740
+7,971
+19% +$798K 0.61% 19
2015
Q1
$4.2M Buy
41,769
+11,838
+40% +$1.2M 0.64% 20
2014
Q4
$3.13M Buy
29,931
+15,930
+114% +$1.68M 0.52% 23
2014
Q3
$1.49M Buy
14,001
+722
+5% +$74.9K 0.28% 33
2014
Q2
$1.39M Buy
13,279
+1,194
+10% +$121K 0.28% 37
2014
Q1
$1.19M Sell
12,085
-20
-0.2% -$1.85K 0.3% 34
2013
Q4
$1.11M Buy
+12,105
New +$1.12M 0.32% 33

Other funds holding JNJ

Brookstone Capital Management's JNJ Position: Q2 2026 in Review

Brookstone Capital Management increased its Johnson & Johnson (JNJ) stake by 138% in Q2 2026, buying an estimated $24.9M and bringing the position to 184,287 shares worth $46.8M. The position accounts for 0.47% of the portfolio, ranked #47.

Brookstone Capital Management first reported a position in JNJ in Q4 2013 and has held it in 51 quarters since. 1,313 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Brookstone Capital Management held 184,287 shares of Johnson & Johnson worth $46.8M as of Q2 2026.
  • Brookstone Capital Management bought 106,805 Johnson & Johnson shares in Q2 2026, an estimated $24.9M.
  • Johnson & Johnson made up 0.47% of Brookstone Capital Management's portfolio in Q2 2026, its #47 holding.
  • Brookstone Capital Management first reported a position in Johnson & Johnson in Q4 2013 and has held it in 51 quarters since.
  • 1,313 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Brookstone Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.